Your browser doesn't support javascript.
Comparison of new and emerging SARS-CoV-2 variant transmissibility through active contact testing. A comparative cross-sectional household seroprevalence study.
Gaskell, Katherine M; El Kheir, Natalie; Mirfendesky, Mariyam; Rampling, Tommy; Marks, Michael; Houlihan, Catherine F; Lemonge, Norbert; Bristowe, Hannah; Aslam, Suhail; Kyprianou, Demetra; Nastouli, Eleni; Goldblatt, David; Fielding, Katherine; Moore, David A J.
  • Gaskell KM; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • El Kheir N; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Mirfendesky M; North Middlesex University Hospital NHS Trust, London, United Kingdom.
  • Rampling T; Hospital for Tropical Diseases, University College London Hospitals Foundation NHS Trust, London, United Kingdom.
  • Marks M; Division of Infection and Immunity, University College London, London, United Kingdom.
  • Houlihan CF; Department of Clinical Virology, University College London Hospitals Foundation NHS Trust, London, United Kingdom.
  • Lemonge N; Department of Population, Policy and Practice, University College London Institute of Child Health, London, United Kingdom.
  • Bristowe H; Department of Population, Policy and Practice, University College London Institute of Child Health, London, United Kingdom.
  • Aslam S; Department of Population, Policy and Practice, University College London Institute of Child Health, London, United Kingdom.
  • Kyprianou D; North Middlesex University Hospital NHS Trust, London, United Kingdom.
  • Nastouli E; Infection, Immunity & Inflammation Department, University College London; Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Goldblatt D; Infectious Disease Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Fielding K; Infectious Disease Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Moore DAJ; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
PLoS One ; 18(4): e0284372, 2023.
Article in English | MEDLINE | ID: covidwho-2295391
ABSTRACT
Historically SARS-CoV-2 secondary attack rates (SAR) have been based on PCR positivity on screening symptomatic contacts; this misses transmission events and identifies only symptomatic contacts who are PCR positive at the time of sampling. We used serology to detect the relative transmissibility of Alpha Variant of Concern (VOC) to non-VOC SARS-CoV-2 to calculate household secondary attack rates. We identified index patients diagnosed with Alpha and non-VOC SARS-CoV-2 across two London Hospitals between November 2020 and January 2021 during a prolonged and well adhered national lockdown. We completed a household seroprevalence survey and found that 61.8% of non-VOC exposed household contacts were seropositive compared to 82.1% of Alpha exposed household contacts. The odds of infection doubled with exposure to an index diagnosed with Alpha. There was evidence of transmission events in almost all households. Our data strongly support that estimates of SAR should include serological data to improve accuracy and understanding.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Journal.pone.0284372

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Journal.pone.0284372